Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination

Published:2023-11-02 Issue:2 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Kainulainen Markus H.¹^ORCID,Harmon Jessica R.¹,Whitesell Amy N.¹,Bergeron Éric¹,Karaaslan Elif¹,Cossaboom Caitlin M.¹,Malenfant Jason H.¹,Kofman Aaron¹,Montgomery Joel M.¹,Choi Mary J.¹,Albariño César G.¹,Spiropoulou Christina F.¹

Affiliation:

1. Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA

Funder

CDC Emerging Infectious Disease Research Core Funds

Centers for Disease Control and Prevention

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2023.2265660

Reference15 articles.

1. Ebola virus disease

2. An outbreak of Ebola in Uganda

3. Notes from the Field: Outbreak of Ebola Virus Disease Caused by Sudan ebolavirus — Uganda, August–October 2022

4. High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice

5. Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge, attitudes, and practices and long-term immune response after rVSVΔG-ZEBOV-GP Ebola vaccination in healthcare workers in high-risk districts in Uganda;Vaccine;2024-09

2. Urgent considerations for booster vaccination strategies against Ebola virus disease;The Lancet Infectious Diseases;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3